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Background: It was recently reported that a limited pulmonary resection (segmentectomy or wedge
resection) was not inferior to a lobectomy in the management of peripheral small-sized adenocarcinoma
(tumor & 20 mm) of the lung.
Methods: We retrospectively analyzed patients undergoing a lobectomy (n ¼ 114) and a limited resection
(n ¼ 35) for peripheral small-sized adenocarcinoma of the lung during a 7-year period from April 2001 to
March 2008. Our criteria for the limited resection of lung cancer were as follows: (1) adenocarcinoma of
10 mm or less in diameter and (2) adenocarcinoma of 11e20 mm in diameter, in which the ratio of the
ground glass opacity is 50% or more, without pleural indentation on computed tomography. Additionally,
the frozen sections of the tumors were intraoperatively diagnosed as Noguchi type A or B. The survival
and clinical outcomes were analyzed.
Results: The 5-year survival rates of the lobectomy group and limited resection groups were 89.2% and
100%, respectively. No recurrence was seen in the limited resection group.
Conclusions: Our results suggest that our criteria for limited resection were adequate for the management
of small-sized adenocarcinoma of the lung.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
As a result of the development of imaging modalities such as
high-resolution computed tomography (HRCT), small-sized lung
cancer is more frequently detected. Although lobectomy is per-
formed as the standard procedure to treat T1N0 non-small cell lung
cancer (NSCLC), limited pulmonary resection, such as segmentec-
tomy or wedge resection, has the theoretical advantage of
preserving pulmonary function and reducing perioperative
mortality and morbidity. Keenan et al.1 retrospectively analyzed
patients undergoing lobectomy and segmentectomy for stage I
non-small cell lung cancer and reported that segmentectomy
was offered to preserve the pulmonary function compared with
lobectomy. Importantly, the survival in both groups was similar
(p ¼ 0.406).
Recent studies demonstrated that the postoperative prognosis
of patients with NSCLC of 2 cm or less in diameter is signiﬁcantlymography; NSCLC, Non-small
: þ81 93 692 4004.
ki).
ciates Ltd. Published by Elsevier Ltbetter than that of patients with a larger tumor.2e5 Although
a lobectomy or pneumonectomy has traditionally been considered
to be the standard procedure for resectable disease, the signiﬁcance
of limited resection as a minimally invasive operation for the
treatment of early adenocarcinoma has become an issue of great
concern with the advancement of video-assisted thoracic surgery.
We evaluated the clinicopathological characteristics and the
follow-up data of patients with completely resected adenocarci-
nomas, and thus determined our criteria for the intentional limited
surgery for non-small cell lung cancer. This article retrospectively
assesses the results of the limited resection and the standard
lobectomy in patients with peripheral small-sized adenocarci-
nomas (tumor & 20 mm) of the lung at the University of Occupa-
tional and Environmental Health.
2. Patients and methods
We analyzed 284 patients that underwent the curative opera-
tion for peripheral small-sized adenocarcinomas (tumor& 20 mm)
of the lung during a 17-year period (1990e2007) to clarify the
indications of limited resection. This period was decided because
a database regarding the surgical, pathological and prognostic
information was available. We regarded a curative resection as and. All rights reserved.
Table 1
Comparison of lymph node metastasis and tumor size in patients with lung cancer
who underwent surgical resection.
Tumor size
(mm)
No. of
patients
N0 N1 N2 N3 Percentages of
patients with
positive node
Non-small cell lung cancer (n ¼ 358)
&10 72 69 0 3 0 4.2%
11e15 122 107 4 10 1 12.3%
16e20 164 131 10 21 2 20.1%
Adenocarcinoma (n ¼ 284)
&10 60 60 0 0 0 0%
11e15 98 87 3 7 1 11.2%
16e20 126 103 5 16 2 18.3%
Table 2
Comparison of lymph node metastasis and GGO ratio in patients with lung cancer
who underwent surgical resection.
(n ¼ 152)
GGO
ratio (%)
No. of
patients
N0 N1 N2 N3 Percentages of
patients with
positive node
<50 90 79 5 6 4 13.9%
S50 62 62 0 0 0 0%
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scopically resected (R0) as speciﬁed by the general rules for the
clinical and pathological record of lung cancer.6 Sixty patients had
tumors of 10mmor less in diameter, 98 had tumors of 11e15mm in
diameter, and 126 had tumors of 16e20 mm in diameter. The
lymph node status after the operations in each tumor size groups
was determined and the percentages of patients with positive node
were 0%, 11.2% and 18.3%, respectively. All of the patients with
adenocarcinomas of 10 mm or less exhibited no lymph node
metastasis (Table 1). Subsequently, we investigated the relationship
between the node status and the ground glass opacity (GGO) ratio
on the HRCT in patients with peripheral small-sized adenocarci-
nomas (tumor & 20 mm) of the lung. Only the patients that
underwent HRCT were analyzed. All the patients had HRCT since
2001. We speciﬁed the GGO ratio as being (1-[maximum dimension
of consolidation of lung windows/maximum dimension of tumor of
lung windows]  100). Ninety patients had tumors of 49% or less in
GGO ratio and 62 patients had tumors of 50% or more. The
percentages of these 2 HRCT patient groups with positive nodes
were 13.9% and 0%, respectively (Table 2). Therefore our criteria for
limited surgery were decided as follows: (1) adenocarcinoma of
10 mm or less in diameter and (2) adenocarcinoma of 11e20 mm in
diameter, in which the ratio of the ground glass opacity is 50% or
more, without pleural indentation on computed tomography. In
addition, the frozen sections of the tumors were intraoperatively
diagnosed to be Noguchi type A or B.
Between April 2001 and March 2008, 516 patients underwent
curative operation for primary non-small cell lung cancer. A total ofFig. 1. 166 patients with peripheral small-sized adenocarcinomas (tumor& 20 mm) of the lu
patients, respectively.149 patients had peripheral small-sized adenocarcinomas
(tumor& 20 mm) of the lung. The observation period ranged from
40 to 2684 days (median: 998 days). Limited resections and stan-
dard lobectomies were performed in 35 and 114 patients, respec-
tively (Fig. 1). All of 35 patients satisﬁed our criteria for limited
resection and underwent the procedure, while the others did not
satisfy the criteria and therefore underwent standard lobectomies
with mediastinal lymph node dissection. The procedure of ﬁrst
choice was segmentectomy. Incidentally, a wedge resection was
selected when the surgical margin could be maintained at 2 cm or
more in width.
2.1. Patient follow-up
All postoperative complications and mortality were recorded.
The patients were followed up at 1-month or at 3-month intervals
for 5 years or more. Physical examinations, routine hematological
analyses, chest radiographies, CTs of the chest and upper abdomen,
magnetic resonance images of the brain, and bone scintigraphy
were performed for evaluations of recurrence.
The survival period rates were calculated by the KaplaneMeier
method and the signiﬁcance of the differences in these rates was
evaluated by the log-rank test.
3. Results
The clinicopathologic ﬁndings of the patients are summarized in
Table 3. All of the patients who underwent limited resection
showed pathological stage IA. In the limited resection group, seg-
mentectomy was performed in 18 patients, and wedge resection
was performed in 17 patients. In the standard lobectomy group,
lobectomy was performed in 111 patients and bilobectomy wasng. Intentional limited resection and standard lobectomy were performed in 35 and 114
Table 3
Characteristics of patients with complete resection for small-size adenocarcinoma of
the lung.
Intentional limited resection
(n: 35)
Lobectomy (n: 114)
Gender
Male 15 Male 64
Female 20 Female 50
Age
41e82 (mean: 67.9) 9e85 (mean: 67.1)
c Stage
c Stage IA 35 c Stage IA 104
c Stage IB 1
c Stage IIA 2
c Stage IIB 1
c Stage IIIA 6
Operation
Segmentectomy 18 Lobectomy 111
Wedge resection 17 Bilobectomy 3
p Stage
p Stage IA 35 p Stage IA 96
p Stage IB 3
p Stage IIA 6
p Stage IIB 1
p Stage IIIA 7
p Stage IIIB 1
Table 5
Recurrence patterns among patients with complete resection for small-size
adenocarcinoma of the lung.
Intensional limited resection (n: 35) Lobectomy (n: 114)
Local recurrence 0 1 (0.9%)
Lymph node recurrence 0 3 (2.6%)
Distant metastasis 0 6 (5.3%)
Lung: 4a
Brain: 1
Bone: 1
a Including overlapped cases.
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were bulky lymph node metastasis and multiple lung cancer.
For the limited resection group, the Noguchi types are shown in
Table 4. Of the patients with tumors measuring 10 mm or less in
diameter, 14 had Noguchi type A or B tumors and 5 had Noguchi C
tumors. Of the patients with tumors measuring 11e20 mm in
diameter which frozen section was diagnosed as Noguchi type A or
B, 13 had Noguchi type A or B tumors and 3 had Noguchi type C
tumors.
The recurrence status in the both groups was summarized in
Table 5. No recurrence was detected in the limited resection group.
The recurrence status in the standard lobectomy group was as
follows: 1 patient had local recurrence: 3 had lymph node recur-
rences: and 6 had distant metastases. Local recurrence was iden-
tiﬁed in a lesion of the parietal pleura, and the one patient
demonstrating local recurrence was found to have pT1N1M0 stage
IIA and Noguchi type F disease.
The overall 5-year survival rates of the limited resection and the
standard lobectomy groups were 100% and 89.2%, respectively
(Fig. 2). Additionally, for the patients with pathological stage IA
disease, the 5-year survival rates of the groups were 100% and
96.9% respectively (Fig. 3). No signiﬁcant difference was detected in
the prognosis between the groups and no perioperative deaths
were recorded in either group.4. Disussion
Landreneau et al.7 compared the results of wedge resection in
102 patients with T1N0 NSCLC with the results of a lobectomy inTable 4
Pathological ﬁndings according to tumor size.
Tumor size&1 cm 1 cm < tumor size& 2 cm
GGO ratio S50%
pleural indentation ()
frozen section: Noguchi A or B
Noguchi A or B 14 (60.9%) 13 (81.3%)
Noguchi C: 5 (21.7%) 3 (18.7%)117 similar patients. They reported a 5-year survival rate of 58% for
patients treated with open wedge resection, 65% for patients
treated with video-assisted wedge resection, and 70% for patients
treated with lobectomy. They concluded that lobectomy should be
indicated for all except for poor-risk patients. After the publication
of these reports, it became difﬁcult to select limited resection as the
resection of choice for low-risk patients with lung cancer in the
United States.
In Japan, the lung cancer mass-screening program supported by
the national government under the Health and Medical Services
Law for the Aged was started in 1987.8 After the nationwide
implementation of this mass-screening program, sometimes
combinedwith chest computed tomographic scanning, the number
of patients given a diagnosedwith small-sized lung cancer has been
increasing. Faced with this situation, in 1992, Tsubota et al.9 began
a multi-institutional clinical study of the treatment of T1N0 NSCLC
(maximum tumor diameter &2 cm) with a segmentectomy. Fifty-
ﬁve patients were enrolled in the study during the ﬁrst 3 years, and
among the patients followed up for a mean of 47 months, the 5-
year survival rate exclusive of deaths unrelated to the lung cancer
was 91%.
Kodama et al.10 conducted a retrospective analysis of patients
with T1N0M0 lung cancer, 46 of whom had undergone limited
resection and 77 of whom had undergone lobectomy. They found
that the tumor diameter tended to be smaller in the limited
resection group, but the 5-year survival rate was higher in the
limited resection group than in the lobectomy group (93% vs 88% in
the lobectomy group). They therefore concluded that a segmen-
tectomy should be considered as an acceptable treatment proce-
dure in such patients.
Yoshikawa et al.11 performed extended segmentectomy in 73
patients with small peripheral lung tumors (maximum tumor
diameter&2 cm). In this resection procedure, the cut line is beyond
the burdened segment after conﬁrming N0 disease by intra-
operative lymph node examination of frozen sections. The 5-year
survival rate for these 73 patients was 91.8%. The decrease in forced
vital capacity was 11.3%  9.8% compared with the preoperative
value. They suggested that an extended segmentectomy was
beneﬁcial in the treatment of patients with small peripheral small
lung tumors.
Koike et al.12 analyzed the survival and clinical outcomes of
patients with peripheral NSCLC (maximum tumor diameter
&2 cm), and compared in the limited resection group (n ¼ 74) and
the lobectomy group (n ¼ 159). They reported that neither the 3-
year nor 5-year survival rates differed signiﬁcantly between the
limited resection group (3-year survival, 94.0%; 5-year survival,
89.1%) and the lobectomy group (3-year survival, 97.0%; 5-year
survival, 90.1%). The clinical outcomes of limited resection were
comparable with that of lobectomy.
Meanwhile, Noguchi et al.13 evaluated the clinicopathologic
characteristics and the prognostic indicators for small-sized
adenocarcinoma of the lung. Two hundred thirty-six patients with
Fig. 2. The overall 5-year survival rates of the intentional limited resection group and the standard lobectomy group were 100% and 89.2%, respectively. No signiﬁcant difference
was detected in the prognosis between the groups.
Fig. 3. 5-year survival rates of the intensional limited resection group and the standard lobectomy group for patients with pathological stage IA disease were 100% and 96.9%,
respectively. No signiﬁcant difference was detected in the prognosis between the groups.
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in diameter were reviewed using Noguchi’s histological classiﬁca-
tion system. The 5-year survival rate for the patients with Noguchi
type A and B tumors (n¼ 22) was 100%. Moreover, the Noguchi type
A and B tumors showed no lymph nodemetastasis.12 It was thought
that peripheral small-sized adenocarcinomas (maximum tumor
diameter &2 cm) classiﬁed as Noguchi type A or B would be an
appropriate candidates for limited surgery.
Based on the ﬁndings of our analysis of peripheral small-sized
NSCLC and numerous other reports, our criteria for a limited
resection were determined to be as follows: (1) adenocarcinoma of
10 mm or less in diameter and (2) adenocarcinoma of 11e20 mm in
diameter, in which the ratio of the ground glass opacity is 50% or
more, without pleural indentation on computed tomography. Inaddition, the frozen sections of the tumors were intraoperatively
diagnosed as Noguchi type A or B. No recurrence was detected in
the intentional limited resection group, although a number of
recurrences were detected in the standard lobectomy group and
the compromised limited resection group. Our results suggested
that our criteria may therefore be appropriate for the surgical
treatment of peripheral small-sized adenocarcinomas of the lung
although a prospective randomized study is still required.Conﬂict of interest
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